A novel 2-piperazino-pyrimidine compound exhibits asexual antimalarial activity by targeting Plasmodium falciparum plasmepsin X
{{output}}
Although the number of cases of malaria has declined since the introduction of artemisinin-based combination therapy in endemic countries, the emergence of resistant parasites in the field has led to an alarming increase in treatment failure, making the search... ...
